Hologic announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval of the company’s ThinPrep Genesis processor for cytology processing and specimen transfer for downstream applications.
Hologic said the new instrument streamlines these workflows with advanced automation capabilities including chain of custody verification, which prevents sample misidentification and allows for more confidence in results. The ThinPrep Genesis processor also includes features such as automated tube and slide labeling, barcode scanning, vial uncapping/capping and sample aliquoting.
